Company says it will cut about 200 employees as value plummets in aftermath of huge data breach
The genetic testing firm 23andMe said on Monday it would cut about 40%, or 200 employees, from its workforce and discontinue further development of all its therapies as part of a restructuring program.
“We are taking these difficult but necessary actions as we restructure 23andMe and focus on the long-term success of our core consumer business and research partnerships,” said the company’s CEO, Anne Wojcicki.
About Author
More Stories
Microsoft unveils chip it says could bring quantum computing within years
I became absorbed in strangers’ fertility journeys online
Virologist Wendy Barclay: ‘Wild avian viruses are mixing up their genetics all the time. It’s like viral sex on steroids’